1. Home
  2. VYGR vs SLMT Comparison

VYGR vs SLMT Comparison

Compare VYGR & SLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.79

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Logo Brera Holdings PLC Class B Ordinary Shares

SLMT

Brera Holdings PLC Class B Ordinary Shares

N/A

Current Price

$1.08

Market Cap

170.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VYGR
SLMT
Founded
2013
2000
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
170.9M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
SLMT
Price
$3.79
$1.08
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
527.4K
847.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$71.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$0.99
52 Week High
$5.55
$24.05

Technical Indicators

Market Signals
Indicator
VYGR
SLMT
Relative Strength Index (RSI) 47.48 32.53
Support Level $2.79 $0.99
Resistance Level $3.73 $2.74
Average True Range (ATR) 0.21 0.14
MACD 0.00 0.03
Stochastic Oscillator 54.65 5.15

Price Performance

Historical Comparison
VYGR
SLMT

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About SLMT Brera Holdings PLC Class B Ordinary Shares

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: